跳轉至內容
Merck
全部照片(1)

重要文件

查看所有文件

03000590

人参皂苷Re

primary reference standard

同義詞:

(3β,6α,12β)-20-(β-D-葡萄糖基吡喃糖基氧基)-3,12-二羟基达玛-24-烯-6-基 2-O-(6-脱氧-α-L-甘露吡喃糖基)-β-D-吡喃葡萄糖苷, NSC 308877, 三七皂苷Re, 人参皂苷B2, 人参皂苷Re, 竹节参皂苷IVc

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C48H82O18
CAS號碼:
52286-59-6
分子量：:
947.15
分類程式碼代碼:
85151701
NACRES:
NA.24

等級

primary reference standard

儲存期限

limited shelf life, expiry date on the label

製造商／商標名

HWI

應用

food and beverages

SMILES 字串

CC1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@H]3C[C@]4(C)[C@H](C[C@@H](O)[C@@H]5[C@H](CC[C@@]45C)[C@](C)(CC\C=C(/C)C)O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@]7(C)CC[C@H](O)C(C)(C)[C@H]37)[C@H](O)[C@H](O)[C@H]1O

InChI

1S/C48H82O18/c1-21(2)11-10-14-48(9,66-42-38(60)35(57)32(54)26(19-49)63-42)23-12-16-46(7)30(23)24(51)17-28-45(6)15-13-29(52)44(4,5)40(45)25(18-47(28,46)8)62-43-39(36(58)33(55)27(20-50)64-43)65-41-37(59)34(56)31(53)22(3)61-41/h11,22-43,49-60H,10,12-20H2,1-9H3/t22-,23-,24+,25-,26+,27+,28?,29-,30+,31-,32+,33+,34+,35?,36-,37+,38+,39+,40-,41-,42-,43+,45+,46+,47+,48-/m0/s1

InChI 密鑰

PWAOOJDMFUQOKB-QVPADXGFSA-N

尋找類似的產品？ 前往 產品比較指南

相關類別

一般說明

Produced and qualified by HWI pharma services GmbH.
Exact content by quantitative NMR can be found on the certificate.

應用

Reference Standard in the analysis of herbal medicinal products

其他說明

This compound is commonly found in plants of the genus: panax

象形圖

Exclamation mark
GHS07

訊號詞

Warning

危險聲明

H302

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

從最近期的版本中選擇一個：

分析證明 (COA)

Lot/Batch Number
HWI02844-1
HWI02844
HWI01844-3
HWI01844-2
HWI01844-1

未看到正確版本？

如果您需要一個特定的版本，您可以透過批號來尋找特定憑證。

搜尋 COA

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Bombi Lee et al.
Journal of microbiology and biotechnology, 22(5), 708-720 (2012-05-09)
In this study, we assessed the effects of ginsenoside Re (GRe) administration on repeated immobilization stressinduced behavioral alterations using the forced swimming test (FST), the elevated plus maze (EPM), and the active avoidance conditioning test (AAT). Additionally, we examined the
Fei Su et al.
Vaccine, 30(27), 4106-4112 (2012-04-05)
Previous studies have demonstrated that ginsenosides Rg1 and Re extracted from the root of Panax ginseng C.A. Meyer have adjuvant properties. However, the molecular mechanisms behind their adjuvant activities remain unclear. In the present study, we first investigated the adjuvant
Souren Paul et al.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 50(5), 1354-1361 (2012-03-10)
This study was undertaken to evaluate the effect of ginsenoside-Re (Gin-Re) isolated from roots of Panax ginseng on carrageenan-induced paw and TPA-induced skin inflammations in experimental mice. Moreover, to confirm further the anti-inflammatory activities of Gin-Re, LPS-induced macrophage activation model
Hai-Yan Quan et al.
International journal of molecular medicine, 29(1), 73-80 (2011-10-06)
Ginsenoside Re is a protopanaxatriol-type saponin isolated from Panax ginseng berry. Although anti-diabetic and anti-hyperlipidemic effects of Re have been reported by several groups, its mechanism of action is largely unknown until now. Here, we examine anti-diabetic and anti-hyperlipidemic activities
Daofeng Qu et al.
Experimental parasitology, 135(2), 234-239 (2013-07-31)
Toxoplasma gondii, the etiological agent of toxoplasmosis, is an obligate intracellular protozoan parasite that infects a variety of mammals including humans. In an attempt to find new antigen-adjuvant combinations that enhance the immunogenicity of antigen candidates for toxoplasma vaccines, we
查看所有相關論文

文章

HPLC Separation: Ginsenosides from American Ginseng

Optimize HPLC method for ginsenoside separation using a mixture, applying it to American Ginseng root, with conditions and chromatograms shown.

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務